These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28582384)

  • 1. The sum of us: considerations on physician-industry relationships.
    Flores Rebollar A
    Medwave; 2017 May; 17(4):e6961. PubMed ID: 28582384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The medical-industrial complex, professional medical associations, and continuing medical education.
    Schofferman J
    Pain Med; 2011 Dec; 12(12):1713-9. PubMed ID: 22145759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Industry support of physician education in the USA.
    Fleischman W; Ross JS
    J Epidemiol Community Health; 2017 Mar; 71(3):213-216. PubMed ID: 27612981
    [No Abstract]   [Full Text] [Related]  

  • 4. CME shelter. Sunshine Act waiver for med ed payments may prompt marketing shift for product makers.
    Lee J
    Mod Healthc; 2014 Jun; 44(26):16-9. PubMed ID: 25134407
    [No Abstract]   [Full Text] [Related]  

  • 5. [Conflict of interest in continuing medical education - Studies on certified CME courses].
    Lenzen LM; Weidringer JW; Ollenschläger G
    Z Evid Fortbild Qual Gesundhwes; 2016; 110-111():60-8. PubMed ID: 26875037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuing medical education and pharmaceutical industry involvement: An evaluation of policies adopted by Canadian professional medical associations.
    Shnier A; Lexchin J
    Int J Risk Saf Med; 2017; 29(1-2):1-16. PubMed ID: 28885217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sunshine Act: shedding light on inaccurate disclosures at a gynecologic annual meeting.
    Thompson JC; Volpe KA; Bridgewater LK; Qeadan F; Dunivan GC; Komesu YM; Cichowski SB; Jeppson PC; Rogers RG
    Am J Obstet Gynecol; 2016 Nov; 215(5):661.e1-661.e7. PubMed ID: 27319366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physician-industry relations. Part 2: organizational issues.
    Coyle SL;
    Ann Intern Med; 2002 Mar; 136(5):403-6. PubMed ID: 11874315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmaceutical industry financial support for medical education: benefit, or undue influence?
    Brody H
    J Law Med Ethics; 2009; 37(3):451-60, 396. PubMed ID: 19723256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physician education and the pharmaceutical industry.
    Johnson RG
    Chest; 2001 Apr; 119(4):995-6. PubMed ID: 11296157
    [No Abstract]   [Full Text] [Related]  

  • 11. Considerations in the relationship between the American College of Chest Physicians and industry.
    Lever A
    Chest; 2001 Apr; 119(4):1257-9. PubMed ID: 11296196
    [No Abstract]   [Full Text] [Related]  

  • 12. [Recomendaciones a los cuerpos directivos de las agrupaciones médicas en su relación con la industria].
    Soda A; Campillo C; Arrieta O; Burgos R; Celis MÁ; Llata M; Domínguez J; Halabe J; Islas S; Jasso L; Lifshitz A; Moreno M; Plancarte R; Reyes A; Ruiz-Argüelles GJ; Verástegui E; Sotelo J
    Gac Med Mex; 2018; 154(5):622-623. PubMed ID: 30407458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Financial support of continuing medical education.
    Steinbrook R
    JAMA; 2008 Mar; 299(9):1060-2. PubMed ID: 18319417
    [No Abstract]   [Full Text] [Related]  

  • 14. [Is it pertinent to investigate the relations between physicians and the drug industry].
    Moliner J; Mozota J; Abad JM; Casaña L; Júdez D; Rabanaque MJ
    Rev Calid Asist; 2009 Apr; 24(2):72-9. PubMed ID: 19426930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient perspectives on physician conflict of interest in industry-sponsored clinical trials for multiple sclerosis therapeutics.
    Solomon AJ; Klein EP; Corboy JR; Bernat JL
    Mult Scler; 2015 Oct; 21(12):1593-9. PubMed ID: 25716879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New guidelines expected in 1991 for relationship of continuing education, financial support.
    Randall T
    JAMA; 1990 Sep; 264(9):1080. PubMed ID: 2384925
    [No Abstract]   [Full Text] [Related]  

  • 17. Successes, challenges emerge from efforts to shift away from industry-funded CME.
    Kuehn BM
    JAMA; 2010 Aug; 304(7):729-31. PubMed ID: 20716730
    [No Abstract]   [Full Text] [Related]  

  • 18. Financial Conflicts of Interest in Continuing Medical Education: Implications and Accountability.
    Barnes B
    JAMA; 2017 May; 317(17):1741-1742. PubMed ID: 28464161
    [No Abstract]   [Full Text] [Related]  

  • 19. Financial ties between leaders of influential US professional medical associations and industry: cross sectional study.
    Moynihan R; Albarqouni L; Nangla C; Dunn AG; Lexchin J; Bero L
    BMJ; 2020 May; 369():m1505. PubMed ID: 32461201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceutical industry support for continuing medical education programs: a review of current ethical guidelines.
    Rosner F
    Mt Sinai J Med; 1995 Nov; 62(6):427-30. PubMed ID: 8692156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.